Authors/Disclosures
|
Kathleen M. Shannon, MD, FAAN
(University of Wisconsin School of Medicine and Public Health)
|
The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. |
|
Bryan A. Bernard, PhD
(Rush University Medical Center)
|
Dr. Bernard has nothing to disclose. |
|
|
No disclosure on file |
|
Gabriel Bsteh, MD
(Medical University Vienna, Department of Neurology)
|
Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene-BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. |
|
Howard Aizenstein, MD, PhD
|
No disclosure on file |